Literature DB >> 26755694

Outcomes From Polyhydramnios With Normal Ultrasound.

Enav Yefet1, Etty Daniel-Spiegel2.   

Abstract

OBJECTIVE: To investigate the short- and long-term outcomes of children from pregnancies complicated with polyhydramnios, defined as amniotic fluid index (AFI) >24 cm, and with a normal detailed ultrasound examination.
METHODS: This retrospective cohort study examined 134 children aged 4 to 9 years with polyhydramnios and normal detailed ultrasound examination during pregnancy compared with 268 controls with normal AFI and normal detailed ultrasound examination matched for maternal age, year of delivery, gestational week at delivery, and presence or absence of diabetes. The primary outcome was the rate of malformations diagnosed postnatally. Additional outcomes were obstetrics outcomes, genetic syndromes, and neurodevelopment.
RESULTS: Polyhydramnios was associated with increased risk for cesarean delivery (CD) and birth weight >90th percentile. This elevation in CD was attributed to increased rate of elective CD due to suspected macrosomia. Polyhydramnios was associated with increased risk for congenital malformations (n = 25 [19%] compared with 27 [10%], respectively; P = .016) without a statistically significant increase in the rate of major malformations (11 [8%] vs. 10 [4%]; P = .057). Genetic syndromes were more prevalent in the polyhydramnios group (5 [3.7%] vs. 2 [0.75%]; P = .043), as were neurologic disorders and developmental delay (9.7% vs. 3%; P = .004).
CONCLUSIONS: Despite a normal detailed ultrasound examination, polyhydramnios is associated with increased rate of fetal malformations, genetic syndromes, neurologic disorders, and developmental delay, which may be diagnosed only after birth.
Copyright © 2016 by the American Academy of Pediatrics.

Entities:  

Mesh:

Year:  2016        PMID: 26755694     DOI: 10.1542/peds.2015-1948

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  3 in total

1.  Amount of polyhydramnios attributable to diabetes may be less than previously reported.

Authors:  Lisa E Moore
Journal:  World J Diabetes       Date:  2017-01-15

2.  Amniotic fluid disorders and the effects on prenatal outcome: a retrospective cohort study.

Authors:  H Bakhsh; H Alenizy; S Alenazi; S Alnasser; N Alanazi; M Alsowinea; L Alharbi; B Alfaifi
Journal:  BMC Pregnancy Childbirth       Date:  2021-01-22       Impact factor: 3.007

3.  Metabolic Profile and Neurogenic Potential of Human Amniotic Fluid Stem Cells From Normal vs. Fetus-Affected Gestations.

Authors:  Giedrė Valiulienė; Aistė Zentelytė; Elizabet Beržanskytė; Rūta Navakauskienė
Journal:  Front Cell Dev Biol       Date:  2021-07-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.